Minneapolis Clinical Trials
Celiac Disease Study
Purpose: to evaluate the safety and tolerability of a potential new drug for the treatment of celiac disease
0 nights
9 visits
Participate in a clinical study of a potential treatment for celiac disease.
Screening: 1 Visit
Outpatient Visits: 9 Visits
Reimbursement for study participation will be provided for time and travel of up to $5,050.
This study has been reviewed and approved by an independent ethics committee.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Participants: Biopsy and serology confirmed celiac disease
Age: 18-70
BMI: 18-40 kg/m2
Medication: Medications approved on case by case basis
Compensation: Up to $5,050
Dose Administration: IV Infusion